Skip to Main Content

Paper Details

Active Surveillance Use Among a Low-risk Prostate Cancer Population in a Large US Payer System: 17-Gene Genomic Prostate Score Versus Other Risk Stratification Methods.
Rev Urol
9
2017
  • 1 - 1

Datasets